GLP-1 family

---

The latest in the GLP-1 peptide line, the 12mg Retatrutide Peptide Pen is for research purposes only. Retratrutide a peptide under investigation as a potential treatment for weight loss, currently having completed Phase 3 clinical trials. As a GLP-1 receptor agonist, it is being studied for its ability to reduce appetite and improve insulin sensitivity. Preliminary research also suggests potential benefits for managing type 2 diabetes and other metabolic conditions such as fatty liver disease.

The pen includes single-use 8mm, 31-gauge needles.

FOR RESEARCH PURPOSES ONLY

• Not for human or animal therapeutic, clinical, or diagnostic use.
   
• Not FDA-approved.
   
• Buyer assumes all responsibility for proper handling, storage, and lawful use.